Jean M. Franchi
Chief Financial Officer
Jean Franchi joined Replimune as Chief Financial Officer in December 2019. Jean brings over 30 years of experience from pre-commercial to global commercial biotech operations. Most recently, she served as the Chief Financial Officer of Merrimack Pharmaceuticals Inc., a company focused on biomarker defined cancers. Prior to Merrimack she was the Chief Financial Officer of Dimension Therapeutics Inc. at the time of the company’s initial public offering in 2015. From 2012 to 2015 Jean was the CFO of Good Start Genetics, a commercial stage genetic screening company. Previously, Ms. Franchi spent 16 years at Genzyme Corporation, where she held roles of increasing responsibility including Senior Vice President of Corporate finance from 2008-2011. From 1995 to 2008 she led the finance function across business units including leading the financial support for Genzyme’s rare disease business that is a recognized world leader in building the rare disease model. Jean received her Bachelor’s degree in Business Administration from Hofstra University.